A high-level overview of NIOX Group Plc (CSSPF) stock. View (CSSPF) real-time stock price, chart, news, analysis, analyst reviews and more.

France-based Keensight Capital has axed plans to acquire British medical device manufacturer Niox Group. Last month, the private equity firm tabled an offer to acquire Niox for £345.8m, or £0.81 ...

Shares of LON NIOX opened at GBX 60.20 ($0.80) on Tuesday. The company has a current ratio of 6.31, a quick ratio of 1.94 and a debt-to-equity ratio of 1.10. The firm has a market cap of £24.73 ...

In March, Paris-based private equity firm Keensight proposed acquiring Niox Group for 345.8 million pounds ($452.4 million), or 81 pence per share - higher than its initial bid of 78 pence per share.

Niox Group plc recently reported that Christopher Mills, associated with Non-Executive Director Nicholas Mills, acquired 8,064 shares of the company’s stock at £0.652 per share.

NIOX COO Adjusts Shareholdings in Strategic Move December 18, 2024 — 01:17 pm EST Written by TipRanks UK Auto-Generated Newsdesk for TipRanks -> ...

Niox added that the current year has started well and that it saw a 18% increase in sales in the first quarter. It had 15.4 million pounds in net cash as of March 31, it said.

British medical device maker Niox Group said on Thursday it had received a sweetened buyout proposal from Parisian private equity firm Keensight Capital, valuing the company at 322.4 million ...

Some investors may remember Niox (NIOX) in its prior incarnation as Circassia, although the change of name has not shifted the company’s emphasis on point-of-care testing for asthma. In the ...

NIOX said the discussions for a private sale are at an early stage and there is no certainty around the terms of any potential offer, or if one will be made. Keensight is required to announce a ...